AN2 Therapeutics, Inc. (ANTX) Return on equity
AN2 Therapeutics, Inc. (ANTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to ANTXSource: SEC XBRL filings · For reference only · Not investment advice
More ANTX financial trends
ANTX RevenueANTX Net incomeANTX Net marginANTX Gross profitANTX Gross marginANTX Operating incomeANTX Operating marginANTX Operating cash flowANTX Free cash flowANTX Capital expendituresANTX Stock buybacksANTX Dividends paidANTX Total assetsANTX Total liabilitiesANTX Shareholders’ equityANTX overview →